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Dopamine D1 receptor inhibition of NMDA receptor
currents mediated by tyrosine kinase-dependent receptor
trafﬁcking in neonatal rat striatum
Huaxia Tong and Alasdair J. Gibb
Department of Pharmacology, University College London, Gower Street, London WC1N 1AS, UK
NMDAreceptorsareofparticularimportanceinthecontrolofsynapticstrengthandintegration
of synaptic activity. Dopamine receptor modulation of NMDA receptors in neonatal striatum
may inﬂuence the efﬁcacy of synaptic transmission in the cortico-striatal pathway and if so,
this modulation will affect the behaviour of the basal ganglia network. Here, we show that in
acute brain slices of neonatal (P7) rat striatum the dopamine D1 receptor agonist SKF-82958
signiﬁcantly decreases NMDA receptor currents in patch-clamp whole-cell recordings. This
inhibition is not abolished by application of a G protein inhibitor (GDP-β-S) or irreversible
Gp r o t e i na c t i v a t o r( G T P - γ-S) suggesting a G protein-independent mechanism. In addition,
intracellular application of protein tyrosine kinase inhibitors (lavendustin A or PP2) abolished
D1 inhibition of NMDA currents. In contrast, in older animals (P28) D1 receptor activation
produces a potentiation of the NMDA response which suggests there is a developmental
switch in D1 modulation of striatal NMDA receptors. Single-channel recordings show that
direct D1 receptor inhibition of NMDA receptors cannot be observed in isolated membrane
patches. We hypothesize that D1 inhibition in whole-cell recordings from neonatal rats may
be mediated by a change in NMDA receptor trafﬁcking. Consistent with this hypothesis, intra-
cellularapplicationofadynamininhibitorypeptide(QVPSRPNRAP)abolishedD1inhibitionof
NMDA receptor currents. We therefore conclude that a tyrosine kinase-dependent alteration
of NMDA receptor trafﬁcking underlies D1 dopamine receptor-mediated down-regulation of
NMDA receptor currents in medium spiny neurons of neonatal rat striatum.
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N-Methyl-D-aspartate (NMDA) receptors play a central
role in excitatory synaptic transmission, plasticity and
excitotoxicity in the brain. NMDA receptor activity can
be regulated by protein kinases (PKA, PKC and tyrosine
kinases) (Blank et al. 1997; Lu et al. 1999; Xiong et al.
1999; Lei et al. 2002) and protein phosphatases (PP1
and calcineurin) (Lieberman & Mody, 1994; Morishita
et al. 2001; Krupp et al. 2002; Rycroft & Gibb,
2004). There is substantial evidence showing that G
protein-coupled receptors such as dopamine receptors
modulate NMDA receptor activity (Blank et al. 1997;
Chen et al. 2004; Cepeda & Levine, 2006; Surmeier et al.
2007). NMDA receptors and dopamine receptors are
colocalized(Fiorentinietal.2003;Scottetal.2006;Cepeda
& Levine, 2006) in striatal medium spiny neurons and the
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interaction between glutamatergic and dopaminergic
input in the striatum is crucial for movement and
behavioural control (Hallett & Standaert, 2004; Calabresi
et al. 2007; Surmeier et al. 2007).
In prefrontal cortex, dopamine D1 receptor activation
has been shown to potentiate NMDA receptor synaptic
currents (Seamans et al. 2001; Chen et al. 2004). In the
striatum, dopamine D1 receptors couple to Gs G proteins
withstimulationoftheclassicaladenylatecyclasepathway
resultinginphosphorylationofDARPP-32andinhibition
ofproteinphosphatase-1(Greengard,2001).Somestudies
have shown that the classical pathway contributes to D1
enhancement of NMDA receptor currents; however, they
have also shown different downstream effectors (Blank
et al. 1997; Cepeda et al. 1998a;F l o r e s - H e r n a n d e zet al.
2002). In addition Dunah & Standaert (2001) have shown
that D1 receptor activation enhances the abundance of
NR1, NR2A and NR2B subunits in the synaptosomal
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membrane fraction of striatal homogenates while Dunah
et al. (2004) have shown that deletion of the gene
for the protein tyrosine kinase, Fyn, inhibits this D1
receptor-induced enhancement.
On the other hand, several studies presented evidence
that dopamine can attenuate NMDA-mediated currents
(Lee et al. 2002; Lin et al. 2003). In particular Lee et al.
(2002) demonstrated inhibition of NMDA responses by a
direct protein–protein interaction between the dopamine
D1 receptor and NR2A subunit C-termini. One possible
hypothesisisthattheseapparentlyconﬂictingresultsofD1
inhibitionorpotentiationcouldbeduetoadevelopmental
switch in D1 modulation that follows the increasing
expressing of NR2A subunits with development.
In this study, we have used striatal medium spiny
neurons from 7-day-old rats as a model system to
investigate D1 modulation of NMDA receptors. At this
developmental stage, D1 receptor activation caused a
decrease of NMDA receptor whole cell currents. This
decrease was not G protein dependent but was abolished
by intracellular application of both a general inhibitor of
tyrosine kinases (lavendustin A) and by the selective Src
tyrosine kinase inhibitor, PP2. Furthermore, intracellular
application of a dynamin inhibitory peptide prevented
D1 inhibition of NMDA currents. Based on these results,
we conclude that G protein-independent D1 inhibition
of NMDA responses in whole-cell recordings is mediated
by a tyrosine kinase-induced change in NMDA receptor
trafﬁcking.
Methods
All animal experiments were carried out in accordance
with the UK Animals (Scientiﬁc Procedures) Act
1986. Every effort was made to minimize animal
suffering and the number of animals used. Seven-day-old
Sprague–Dawley rats were killed by decapitation and
horizontal striatal slices (300μm thick) were made using
a vibroslicer (Dosaka DTK 1000, Ted Pella Inc., Reading,
CA, USA) by cutting the brain in an ice-cold (<4◦C)
oxygenated slicing solution of composition (in mM):
sucrose, 206; KCl, 2.5; CaCl2, 1.0; MgCl2,1 . 0 ;N a H 2PO4,
1.25; NaHCO3, 26; glucose, 25; pH7.4. Slices were
maintained for 1–8h at room temperature (20–24◦C) in
Krebs solution containing (in mM): NaCl, 125; KCl, 2.5;
CaCl2, 1.0; MgCl2,2 . 0 ;N a H 2PO4, 1.25; NaHCO3, 26;
glucose, 25; TTX 0.0001; pH7.4. Slices were viewed on
the stage of an upright microscope (Zeiss Axioscope FS)
using Normaski differential interference contrast optics
(Edwards et al. 1989). Healthy striatal medium spiny
neuronssuitableforpatch-clampingwereidentiﬁedinthe
slice by their location, size and morphology (Gotz et al.
1997).
During recording, slices were bathed in Mg-free Krebs
solution containing (in mM): NaCl, 125; KCl, 2.5; CaCl2,
1.0; NaH2PO4, 1.25; NaHCO3, 26; glucose, 25; TTX
0.0001; pH7.4 continuously gassed with a mixture of O2
(95%) and CO2 (5%). Recordings were made with patch
pipettes ﬁlled with pipette solution containing (in mM):
CsCl2,140;EGTA,10;Hepes,10;NaCl,10;MgCl2,1;A TP ,
1; GTP, 1 (or GDP-β-S, 0.5 or GTP-γ-S, 0.5); adjusted to
pH7.4 with NaOH.
P a t c hp i p e t t e sw e r ep u l l e df r o mt h i c k - w a l l e d
borosilicate glass capillaries (GC150F-7.5, Harvard
Apparatus Ltd) and ﬁre polished on a microforge
(Narishige MF-83) to a ﬁnal resistance of 6–15M .
For single channel recordings, pipettes were coated with
an insulating silicone resin (Sylgard 184, Dow Corning,
USA). Both whole cell and single channel currents were
recorded at a membrane potential of −60mV at room
temperature (20–24◦C). In whole-cell recordings series
resistance compensation between 75 and 90% was used.
NMDA currents were evoked by 2min applications
of NMDA (10μM)a n dg l y c i n e( 1 0 μM) followed by
a 5min application of the dopamine D1 receptor
agonist SKF-82958 (20nM) in the presence of the D2
receptor antagonist spiperone (2nM). Finally we applied
SKF-82958 (20nM) and spiperone (2nM) accompanied
by NMDA (10μM)a n dg l y c i n e( 1 0 μM) for 2min.
These concentrations of SKF-82958 and spiperone were
chosen to give 83% D1 receptor occupancy by SKF-82958
and more than 95% D2 receptor block by spiperone
based on equilibrium constants of 4nM and 73nM for
SKF-82958 binding to D1 and D2 receptors, respectively,
and 220nM and 0.08nM for spiperone binding to D1 and
D2 receptors (Mottola et al. 1996; Kebabian et al. 1997).
At these concentrations of dopamine receptor ligands,
the possibility of direct effects on the NMDA receptor
that occur at much higher concentrations is minimized
(Castro et al. 1999; Cui et al. 2006). In outside-out patch
experiments,thepatchwasﬁrstexposedtoNMDA(1μM)
and glycine (10μM) for 2min, followed by SKF-82958
(20nM) and spiperone (2nM) with NMDA and glycine
for 2–3min following an equilibration period of 1min.
Whole cell and single channel currents were recorded
using an Axopatch 200A patch-clamp ampliﬁer (Axon
Instruments). Signals were ampliﬁed and ﬁltered at 2kHz
(8poleBessel)anddigitizedat20kHzusingananalog-to-
digital converter (CED 1401plus, Cambridge Electronic
Design, UK), and stored on computer using the program
WinEDR (V2.2.3 available at http://spider.science.strath.
ac.uk/PhysPharm/showPage.php?pageName=software
ses). Single channel analysis software was designed by
Prof D. Colquhoun (can be requested at http://www.
ucl.ac.uk/Pharmacology/dc.html).
Eachdigitizedsinglechannelrecordwasanalysedusing
‘SCAN’, an interactive computer program. Display and
analysis of single channel data distributions was done
using the program ‘EKDIST’ (Colquhoun & Sigworth,
1995). Before analysis, a ﬁxed resolution for open times
C   2008 The Authors. Journal compilation C   2008 The Physiological SocietyJ Physiol 586.19 D1 inhibition of striatal NMDA receptor currents 4695
and closed times that gave a false event rate less than
10−11 events per second was imposed. Before a patch was
accepted for detailed analysis, the long-term stability of
the data records was checked by making stability plots
for amplitudes (using the amplitude of openings longer
than 2.0 ﬁlter rise times: 332μs), open times, shut times
and Popen (Colquhoun & Sigworth, 1995). Stability plots
for open and shut times were made by calculating a
moving average of 50 consecutive open or shut time
intervals with an overlap of 25 events and plotting this
average against the interval number at the centre of the
averaged values. Stability plots for open probability were
made by calculating a Popen value for each set of 50
open and shut times. Once the stability of the record
had been conﬁrmed, amplitude distributions were made
containing individual channel amplitudes longer than
332μs (2.0 ﬁlter rise times). Distributions of channel
amplitudes were ﬁtted with the sum of three Gaussian
components with the standard deviation constrained to
bethesameforeachcomponent(Colquhoun&Sigworth,
1995). Direct transitions between channel conductance
levelswereidentiﬁedusinganamplitude-basedseparation
of unitary currents using critical amplitude values (Acrit)
calculated from the Gaussian components ﬁtted to the
amplitude distribution (Colquhoun & Sigworth, 1995).
Each amplitude level had a minimum duration longer
than 2.5 ﬁlter rise times (415μs), without intervening
closures longer than the shut time resolution (120μs).
Distributions of channel open times or closed times were
ﬁttedusingthemaximumlikelihoodmethod(Colquhoun
& Sigworth, 1995) with probability density functions that
were a mixture of three exponential components for open
times and ﬁve exponential components for closed times
(Gibb & Colquhoun, 1992).
For statistical comparisons, Student’s t tests and a
randomizationtestwasusedthatdoesnotinvolvemaking
any assumptions about the shape of the distribution
of observations (this can be requested at http://www.
ucl.ac.uk/Pharmacology/dcpr95.html). Statistical
signiﬁcance was set at P<0.05.
Results
Experiments were carried out upon medium spiny
neurons in striatal brain slices from 7-day-old rats.
Mediumspinyneuronsconstituteabout90%ofthestriatal
neuron population (Jain et al. 2001; Rymar et al. 2004),
and their size means that when viewed under Normarski
opticsinacutebrainslicestheyareeasytodistinguishfrom
the much rarer, large interneurons (Gotz et al. 1997).
Medium spiny neurons were voltage clamped at
−60mV in the presence of TTX (100nM)t ob l o c k
voltage-gated Na+ currents. NMDA (10μM)a n dg l y c i n e
(10μM)wereappliedfor2mintomeasurethesteady-state
whole-cell NMDA current. SKF-82958 (20nM), a D1
receptorselectiveagonist,wasusedtoactivateD1receptors
in the presence of the D2 receptor antagonist spiperone
(2nM) to avoid D2 receptor activation. SKF-82958 and
spiperonewereappliedfor5minintheabsenceofNMDA
and then for 2min in the presence of NMDA and glycine
(Fig.1A). In each slice only one whole cell recording was
made in the presence of SKF-82958.
D1 receptor activation reduced NMDA receptor
currents in striatal medium spiny neurons
The D1 receptor agonist SKF-82958 signiﬁcantly
(P<0.05) decreased the NMDA whole-cell current
from 249±36pA to 153±31pA (mean± S.E.M., n=10
neurons) (Fig.1A). To conﬁrm this inhibition, in a
separate group of slices we made control experiments in
15 cells where two consecutive NMDA responses, 5min
apart, were recorded without application of SKF-82958
or spiperone (Fig.1B). In these experiments there was
no signiﬁcant change (−3.1±6.0%) in the second
NMDA response (246±61pA) when compared with the
ﬁrst NMDA response (258±58pA), while in contrast
SKF-82958 signiﬁcantly decreased the second NMDA
responseby34.2±12.3%(P<0.05)(Fig.1D).Moreover,
experiments in the presence of the D1 antagonist
SCH-23390 (300nM;F i g . 1 C) blocked the SKF-82958
induced inhibition of the NMDA responses (control
173±28pA; SCH-23390+SKF-82958 167±34pA;
n=10, P>0.05). These results also demonstrate that
the presence of the D2 receptor antagonist spiperone,
and hence block of any constitutive D2 tone in the slice,
did not signiﬁcantly affect NMDA responses. It is clear
that D1 receptor activation in neonatal striatal medium
spiny neurons reduced by about one-third the NMDA
receptor-mediated whole-cell currents.
D1 inhibition of NMDA receptor currents in neonatal
rats changes to potentiation with development
InordertoinvestigateiftheeffectofD1receptoractivation
changes with development, experiments equivalent to
those made with P7 rats were made with rats aged
P21 and P28. In these experiments at age P21 there
was no signiﬁcant change (+11.3±21.7%, P>0.05,
n=9) in the second NMDA response in the presence
of SKF-82958 and spiperone (382±120pA) when
compared with the ﬁrst NMDA response (338±77pA).
In contrast, at P28 SKF-82958 signiﬁcantly increased
by 45.6±19% (P<0.05, n=6) the second NMDA
response (643±187pA) compared to the ﬁrst response
(399±102pA) (Fig. 2). Moreover, experiments in the
presence of the D1 antagonist, SCH-23390 (300nM),
blocked the SKF-82958 induced enhancement at
P28 of the NMDA responses (control 562±193pA;
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Figure 1. D1 receptor activation inhibits whole cell NMDA
receptor currents recorded from 7 day-old rat striatal neurons
A, response to NMDA (10 μM) and glycine (10 μM) applied for 2 min,
followed by 5 min SKF-82958 (20 nM) and spiperone (2 nM), and
ﬁnally NMDA (10 μM), glycine (10 μM), SKF-82958 (20 nM)a n d
spiperone (2 nM) for 2 min. Brief downward deﬂections of the current
trace show occasional miniature synaptic currents. B, response to
NMDA and glycine applied for 2 min, followed by 5 min of control
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Figure 2. Developmental changes in D1 receptor modulation of
whole cell NMDA receptor currents recorded in striatal neurons
from 7-day-old (P7), 21-day-old (P21) and 28-day-old (P28) rats
D1 receptor activation produced a signiﬁcant (∗P < 0.05, n = 10)
inhibition of the NMDA current in P7 neurones, inconsistent effects at
P21 (n = 9) and a signiﬁcant (∗P < 0.05, n = 6) potentiation of the
NMDA response at P28.
SCH-23390+SKF-82958 + spiperone 501±184pA;
n=6,P>0.05).AlthoughthesizeoftheNMDAresponse
increased between P7 (251±27pA, n=32) and P28
(476±102pA,n=12cells,P<0.05),cellcapacitancedid
notsigniﬁcantly(P>0.05)increaseoverthisagerange(P7
19.4±1.0pF, n=92; P28 23.4±3.4pF, n=10).
Neither G proteins nor PKA are involved in D1
inhibition of neonatal NMDA receptor currents
In order to test whether G proteins are required for D1
receptor inhibition of whole cell NMDA currents, intra-
cellularGTP(1 mM)wasreplacedwithageneralGprotein
inhibitor,GDP-β-S(0.5mM),innineneurons.SKF-82958
still signiﬁcantly decreased the NMDA whole-cell current
from 162±34pA to 74±12pA (54±12% inhibition,
n=9c e l l s )( F i g . 3 A). Likewise, replacement of GTP
with GTP-γ-S (0.5mM), an irreversible activator of
G proteins, did not occlude the SKF-82958 induced
inhibition of NMDA responses (NMDA 365±52pA;
SKF-82958 + NMDA 209±27pA; n=10 cells, P<0.05,
recording solution, followed by NMDA and glycine for 2 min. C,
response to NMDA (10 μM) and glycine (10 μM) applied for 2 min,
followed by 5 min SKF-82958 (20 nM), SCH-23390 (300 nM)a n d
spiperone (2 nM), and ﬁnally NMDA (10 μM), glycine (10 μM),
SKF-82958 (20 nM), SCH-23390 (300 nM) and spiperone (2 nM)f o r
2m i n .D, mean percentage change (± S.E.M.) in NMDA current in the
presence of SKF-82598 and spiperone (unpaired t test P < 0.05), in
the presence of SKF-82598, spiperone and SCH-23390, and from
control experiments involving two successive NMDA responses.
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43±6% inhibition) (Fig.3B). The results suggest that
G protein activation is not involved in D1 inhibition of
NMDA responses. However, the mean NMDA response
in the presence of G protein inhibition (GDP-β-S) is
signiﬁcantlysmaller(162±34pA)thaninthepresenceof
anirreversibleGproteinactivator,GTP-γ-S(365±52pA)
although these were not signiﬁcantly different to the
control currents (ANOVA, P<0.05). Therefore these
results also indicate that G protein activation can
potentiate NMDA responses in striatal neurons, although
they give no information about the type of G protein
involved.
Activation of cAMP-dependent protein kinase (PKA)
c o u l db ei n v o l v e di nD 1r e c e p t o rm o d u l a t i o no fN M D A
receptors via the classical adenylate cyclase pathway
(Greengard, 2001). To test for a role for PKA in D1
inhibition here, H-89 (5μM), a PKA inhibitor, was added
to the pipette solution which contained ATP (1mM)
and GTP (1mM)( F i g . 3 C). H-89 did not signiﬁcantly
affect the control NMDA response and did not block
thesigniﬁcantattenuationofNMDAresponses(33±9%,
n=7, P<0.05) induced by SKF-82958 (Fig.3C). These
results show that PKA activation is not required for D1
inhibition of NMDA receptor currents in medium spiny
neurons. Since neither G proteins nor PKA were involved
inD1inhibitionofNMDAresponsesintheseexperiments,
we conclude an alternative mechanism may predominate
here.
D1 inhibition is not evident in single-channel
recordings
In order to investigate whether D1 inhibition of NMDA
receptors could be observed in isolated membrane
patches, we made outside-out patch-clamp recordings
from medium spiny neurons in 21 different striatal
slices from 7-day-old rats. In these experiments GDP-β-S
(0.5mM)a n dA T P( 1 m M) were present in the pipette
solutionaswhole-cellrecordingsdemonstratedthatactive
G proteins are not necessary to observe D1 inhibition and
TTX(100nM)wasappliedintherecordingsolution.Single
channel openings were evoked by NMDA (1μM)a n d
glycine (10μM)a t−60 mV, and were recorded for 2 min
both in the absence of SKF-82958 (20nM) and spiperone
(2nM) (control) and in their presence. Examination
of individual single channel recordings illustrates that
SKF-82958 produced no obvious changes in NMDA
channel behaviour (Fig.4A and B).
Quantitative analysis of single channel distributions
conﬁrmed that D1 modulation of the NMDA receptor
activity was not evident in outside-out patches
(Supplemental Fig.1S). Channel open probability was
0.043±0.010 for control and 0.058±0.017 in the
presence of SKF-82958 (Fig.4C). Neither the time
constants nor the relative areas of the exponential
components ﬁtted to open time or closed time
distributions were signiﬁcantly changed in the presence
of SKF-82958 (Supplemental Fig.1S). The mean open
time was 2.74±0.39ms for control and 3.36±0.50ms
in the presence of SKF-82958 (Fig.4D). The mean shut
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Figure 3. G proteins and PKA are not involved in D1 inhibition
of NMDA responses
A, mean current (± S.E.M.) in the presence of intracellular GDP-β-S
(0.5 mM) of the ﬁrst NMDA response compared to the second
response in the presence of SKF-82958 and spiperone (n = 9,
P < 0.05). B, mean current (± S.E.M.) in the presence of intracellular
GTP-γ-S (0.5 μM) of the ﬁrst NMDA response compared to the second
NMDA response (n = 10, P < 0.05). C, mean current (± S.E.M.) in the
presence of intracellular H-89 (5 μM) of the ﬁrst NMDA response
compared to the second NMDA response in the presence of
SKF-82958 and spiperone (n = 7, P < 0.05).
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times were 167±37ms for control and 160±46ms in
thepresenceofSKF-82958(Fig.4E).ThereforeSKF-82958
did not signiﬁcantly change the NMDA receptor single
channel properties in outside out patches.
Figure 4. Single channel activity mediated by NMDA receptors in control (A)a n d2 0 n M SKF-82958
treated (B) outside-out patches
Downward deﬂections in the baseline indicate single channel openings in the presence of 1.0 μM NMDA and
10 μM glycine. Both A and B show 5 s of continuous recording at a holding potential of −60 mV from the same
patch. Currents were low-pass ﬁltered at 2 kHz and digitized at 20 kHz. Mean channel open probability (C), open
time (D) and shut time (E) were not altered signiﬁcantly in the presence of SKF-82958.
Subunit composition of neonatal striatal medium
spiny neurone NMDA receptors
Our results showing D1 inhibition of NMDA currents
are similar in some ways to those of Lee et al.
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(2002). However, they identiﬁed direct protein–protein
interactions between the C-terminus of the D1 receptor
(D1-t3) and the C-terminus of the NR2A subunit
as involved in inhibition of NMDA currents in both
transfected cell lines and in tissue cultured striatal
and hippocampal neurones. In our outside-out patch
experiments, stability plots (Colquhoun & Sigworth,
1995) of single channel amplitude measurements
(Supplemental Fig.2SA and B) showed that channel
activity was stable during the recording period and that a
varietyofsinglechannelcurrentamplitudesareseeninthe
presence of NMDA, with the largest of these around 3pA
in size corresponding to 50pS conductance at −60mV.
Single NMDA channel amplitude distributions were
ﬁtted with the sum of three Gaussian components both in
control and in the presence of SKF-82958 and spiperone
(SupplementalFig.2SC andD).Meanvalues(andrelative
areas) for these three components were 1.1±0.1pA
(18±4%), 1.9±0.1pA (48±7%), 3.05±0.2pA
(33±7%) for control and 1.1±0.1pA (23±4%),
1.9±0.1pA (45±7%), 2.9±0.1pA (34±7%) in the
presence of SKF-82958, corresponding to average single
channel conductances of 18pS, 32pS and 50pS. Some
evidence for receptor heterogeneity was apparent in
these recordings with some patches, as illustrated in
Fig. 4, exhibiting a majority of large (50pS) openings,
while in other patches intermediate and low (18pS)
conductanceopenings were more common. Large (50pS)
conductance single channel openings are characteristic of
NR2Aand/orNR2Bsubunit-containingNMDAreceptors
(Stern et al. 1992) while small conductance openings
are characteristic of NR2C or NR2D subunit-containing
receptors (Stern et al. 1992; Wyllie et al. 1996). We
therefore tested in whole-cell recordings for the presence
of functional NR2A-containing receptors (Paoletti et al.
1997) using ZnCl2 (100nM) or for the presence of
tonic zinc inhibition using the zinc chelating agent
N,N,N ,N -tetrakis(2-pyridylmethyl)ethylenediamine
(TPEN; 1μM) (control 194±20pA; ZnCl2 198±15pA;
TPEN 181±11pA; n=5 cells). There was no signiﬁcant
difference among these three NMDA responses. In
contrast, the NR2B selective antagonist ifenprodil
(10μM) produced a 68.1±8.9% inhibition of the
response to 200μM NMDA and 10μM glycine (control
862±131pA; ifenprodil 275±76pA; n=11). A
saturating concentration of NMDA was used in these
experiments in order to avoid underestimating the
effect of ifenprodil due to the increase in agonist
afﬁnity that accompanies ifenprodil binding to NR2B
receptors (Kew et al. 1996). In addition, single channel
recordings showed that ifenprodil (10μM) decreased
mean open time from 2.92±0 . 2 m si nc o n t r o lt o
0.77±0.12ms as expected if ifenprodil were acting at
NR2B receptors to increase receptor proton sensitivity
(Banke et al. 2005). These results suggested an absence
of functional NR2A receptors and a predominance of
NR2B subunit-containing receptors in 7-day-old rat
striatum, while the presence of low-conductance (18pS)
single channel openings suggests the presence of NR2C
or NR2D subunits. NR2D subunit-containing receptors
display direct transitions between conductance levels that
are asymmetric in their frequency when they involve the
18pS conductance level (Wyllie et al. 1996) while NR2C
subunit-containing receptors do not show this effect
(Sternetal.1992).Inourexperimentsonneonatalstriatal
neurones direct transitions involving the 18pS level
were asymmetric with transitions from 50pS to 18pS
occurring more frequently (58±1.8% of transitions,
n=11 patches) than transitions from 18pS to 50pS
(42±1.8%) and transitions from 32pS to 18pS were
also more frequent (57±2.9%) than from 18pS to
32pS (43±2.9%). In contrast, transitions between 50pS
and 32pS levels were symmetrical in their transition
frequency (49.1±2.4% and 50.9±2.4%). Application
of SKF-82958 did not change the frequencies of direct
transitions. Intermediate conductance receptors (32pS)
could be due to the presence of NR3A subunit-containing
receptors (P´ erez-Ota˜ no et al. 2001; Wong et al. 2002) or
due to triheteromeric receptors containing two types of
NR2 subunit (Chefﬁngs & Colquhoun, 2000). Similarly,
protein immunohistochemistry (Portera-Cailliau et al.
1996; Wenzel et al. 1997; Wong et al. 2002) and in situ
mRNA hybridization (Monyer et al. 1994; Wenzel et al.
1997) show a lack of NR2A and NR2C and the presence
of NR2B (Portera-Cailliau et al. 1996; Wenzel et al. 1997)
and low levels of NR2D (Dunah et al. 1996) and NR3A
(Wong et al. 2002) subunit expression in P5–P7 rat
striatum. Thus NR2A subunits may not be involved in
D1 inhibition of striatal NMDA receptors at this stage of
development whereas it is likely that NR2B and NR2D
containing receptors are.
Since whole-cell currents are determined by the
channel conductance, open probability and the number
of channels, these results suggested that D1 inhibition of
NMDA responses in whole-cell recordings could be due
to a change in the number of surface NMDA receptors
suggesting an effect on NMDA receptor trafﬁcking.
Non-receptor tyrosine kinase inhibitors blocked D1
inhibition
Non-receptor tyrosine kinases have been shown to
modulate NMDA receptor trafﬁcking in a range of
preparations,includinginthestriatumwherebiochemical
studies have shown clear evidence for a role of tyrosine
kinases in regulating receptor trafﬁcking (Dunah &
Standaert, 2001; Dunah et al. 2004). In our initial
experiments, lavendustin A (10μM), a non-selective
inhibitor of non-receptor tyrosine kinases (Onoda et al.
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1989; Lu et al. 1999), was used to investigate the
mechanism of D1 modulation of NMDA responses
(Fig.5A).InthepresenceofintracellularlavendustinA,D1
inhibitionoftheNMDAcurrentwassigniﬁcantlyreduced
from 34.2±12.3% (Fig.5A)t o1 ±8.7% (n=14 cells,
unpaired t test, P<0.05), whereas its inactive analogue
lavendustin B did not affect the D1 inhibition (40±4%
inhibition, n=8). Intracellular lavendustin A did not
signiﬁcantly affect the size of control NMDA responses
(control 249±36pA; lavendustin A 205±77pA). In a
second series of experiments, the effects of SKF-82958
weretestedduringintracellularapplicationoftheselective
Src tyrosine kinase inhibitor, PP2 (10μM). In these
experiments there was no signiﬁcant difference between
the NMDA response in control (282±69pA) compared
to the NMDA response in the presence of SKF-82958 and
spiperone (262±57pA, n=9, P>0.05) (Fig.5B). These
results suggest active tyrosine kinase is necessary for D1
receptor inhibition of NMDA responses.
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Figure 5. D1 inhibition of NMDA responses is non-receptor
tyrosine kinase dependent
A, in the presence of intracellular lavendustin A (10 μM), the mean
NMDA current (± S.E.M.), compared to the second NMDA response in
the presence of SKF-82958 and spiperone (n = 14, P > 0.05). B, in the
presence of intracellular PP2 (10 μM), the mean NMDA current
(± S.E.M.) compared to the second response in the presence of
SKF-82958 and spiperone (n = 9, P > 0.05).
Intracellular dynamin inhibitory peptide abolished D1
inhibition
Dynamin plays an essential role in clathrin mediated
endocytosis (Schmid, 1997), which has been shown
to mediate endocytosis of GABAA receptors (Kittler
et al. 2000), AMPA receptors (Carroll et al. 1999)
and NMDA receptors (Nong et al. 2003; Newpher &
Ehlers, 2008). Here we applied intracellular dynamin
inhibitory peptide (QVPSRPNRAP; 50μM)t op r e v e n t
receptor endocytosis (Fig.6A). In whole cell recordings,
the response to bath application of NMDA reﬂects
activation of both synaptic and extra-synaptic NMDA
receptorsandisthuslikelytobeunaffectedbymechanisms
inﬂuencing the surface movement of receptors between
synaptic and extra-synaptic membranes (Groc et al.
2006; Newpher & Ehlers, 2008). In the presence of
dynamin inhibitory peptide, NMDA responses were
signiﬁcantly increased compared to all other control
NMDA responses (Fig.6B). Control currents recorded
with our standard pipette solution averaged 251±27pA
(n=32) whereas in the presence of intracellular
dynamin inhibitory peptide, control currents averaged
497±62pA (n=18). D1 inhibition of NMDA responses
was abolished by intracellular dynamin inhibitory
peptide;the average percentageinhibition decreasedfrom
34.3±12.3% (Fig.1B)t o−1.1±8.2% (Fig.6C)( n=9
cells). In control experiments, intracellular application
of a myristolated scrambled dynamin inhibitory peptide
(Myr-QPPASNPRVR, 50μM) was used to test the
selectivity of the effect of the dynamin inhibitory peptide
effect on D1 inhibition. In the presence of the scrambled
dynamin inhibitory peptide, SKF-82958 signiﬁcantly
reducedthemeanNMDAresponses(from168±31pA,to
127±27pA) by 25±4% (n=9, P<0.05). These results
suggest dynamin-dependent endocytosis is essential in
order to observe D1 inhibition of NMDA responses.
In nine control experiments where two successive
NMDA responses were evoked in cells dialysed with
50μM dynamin inhibitory peptide, without application
of SKF-82958, there was no signiﬁcant difference between
ﬁrst and second NMDA responses (ﬁrst responses
569±86pA; second responses 526±93pA) suggesting
dynamin-independent processes involving the NMDA
receptors had reached a steady-state within the ﬁrst
few minutes of whole-cell recording. If we assume
that dynamin-dependent receptor internalization is the
dominant NMDA receptor internalization mechanism,
these results suggest that approximately 50% of NMDA
receptors are located on the cell surface at any one time
(average current increased from 251pA in control to
497pAinthepresenceofthedynamininhibitorypeptide).
Furthermore, since the NMDA current in the presence of
dynamin inhibition was stable within 5min of beginning
whole-cell recording, these results suggest an estimate of
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the lifetime of a surface receptor (at room temperature)
of around 1.0min (given exponential processes normally
require around ﬁve time constants for establishment of
a new steady-state). Given that NPopen in outside-out
patches was approximately 0.05 at 1μM NMDA, then
assuming an EC50 for NMDA of 20μM and a maximal
singlechannelopenprobabilityof0.2(Gibb&Colquhoun,
1992;Rycroft&Gibb,2002),ouraveragecontrolresponse
of 250pA at −60mV corresponds to a total of 1250
NMDA receptors on the cell surface and this increases to
2500 receptors in the presence of the dynamin inhibitory
peptide.
Discussion
Dopamine modulation of NMDA receptors in the
striatum is not only crucial to the efﬁcacy of synaptic
transmission in the cortico-striatal pathway (Calabresi
et al. 2000; Centonze et al. 2003) but may also inﬂuence
excitotoxicity in some neuronal pathologies. NMDA
receptor-dependent long-term potentiation (LTP) and
long-termdepression(LTD)havebeendescribedinseveral
brain areas including the striatum (Calabresi et al. 1992;
Charpier & Deniau, 1997) and NMDA receptor mediated
excitotoxicity contributes to the death of striatal neurons
undersomepathologicalconditions(Koroshetzetal.1990;
Cepeda et al. 1998b;Z e r o net al. 2002; Li et al. 2003).
In this study we have shown that dopamine D1 receptor
activationattenuatesNMDAreceptorcurrentsinneonatal
striatal medium spiny neurons. Our experimental data
suggestthisisaGprotein-independent,Srcfamilytyrosine
kinase-mediated mechanism involving NMDA receptor
trafﬁcking.
G protein-independent NMDA receptor inhibition
In whole cell recordings, D1 receptor activation by
SKF-82958 signiﬁcantly decreased NMDA receptor
currents in striatal medium spiny neurons. This
result is not consistent with the hypothesis of the
classical adenylate cyclase pathway involving GS G
protein stimulation, where D1 activation has been
shown to enhance NMDA responses via the adenylate
cyclase–protein kinase-A and DARPP-32 (dopamine
and cyclic adenosine 3 ,5 -monophosphate-Regulated
PhosphoProtein, 32kDa) cascade (Levine et al. 1996;
Blank et al. 1997; Flores-Hernandez et al. 2002). In our
experiments D1 inhibition of NMDA receptor currents
could not be abolished by intracellular application of
either GDP-β-S (an inhibitor of G protein function)
or occluded by GTP-γ-S (an irreversible activator of G
proteins), which strongly suggests that in these young
mediumspinyneuronesD1receptoractivationattenuates
NMDA receptor currents by a G protein-independent
mechanism. In addition, the PKA inhibitor H-89 did not
affect D1 inhibition.
These results are similar in some ways to those of Lee
et al. (2002). They identiﬁed direct protein – protein
interactions between the C-terminus of the D1 receptor
(D1-t3) and the C-terminus of the NR2A subunit which
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Figure 6. Intracellular dynamin inhibitory peptide (50 μM)
abolishes D1 inhibition of whole cell NMDA receptor currents
A, response to NMDA (10 μM) and glycine (10 μM) applied for 2 min,
followed by 5 min of SKF-82958 (20 nM) and spiperone (2 nM), and
ﬁnally NMDA (10 μM), glycine (10 μM), SKF-82958 (20 nM)a n d
spiperone (2 nM)f o r2m i n .B, mean current (± S.E.M.) of the ﬁrst
NMDA response compared to the second response in the presence of
SKF-82958 and spiperone (n = 9, P > 0.05). C, mean percentage
SKF-82958 inhibition (± S.E.M.) in experiments with only ATP and GTP
in the pipette solution (Fig. 1A) compared to experiments in the
presence of 50 μM intracellular dynamin inhibitory peptide (unpaired
t test P < 0.05).
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led to inhibition of NMDA receptor currents that was
not dependent on G proteins or PKA. However, their
results also showed that the carboxyl tail of NR2B could
not form a complex with the D1 receptor directly. In
our experiments we could not ﬁnd evidence for the
presence of functional NR2A subunits in the striatum of
7-day-old rats using either the zinc chelating agent TPEN
to unmask any tonic zinc inhibition of NR2A receptors
or addition of zinc to cause inhibition of NR2A receptors
(Paoletti et al. 1997). These results are consistent with
the absence or very weak expression of NR2A mRNA
(Monyer et al. 1994; Wenzel et al. 1997) or protein
(Portera-Cailliau et al. 1996; Dunah et al. 1996; Wenzel
et al. 1997) from the striatum of P5–P7 rats. At postnatal
daysP5–P7thereisastrongexpressionoftheNR2BmRNA
(Monyer et al. 1994) and protein (Portera-Cailliau et al.
1996; Wenzel et al. 1997) in the striatum (Standaert et al.
1994; Wenzel et al. 1997) and only low levels of NR2D
subunit protein are detected (Dunah et al. 1996), which
is consistent with the large single channel conductance
(50pS) observed and lower conductance events (18pS)
in outside-out patch recordings in these experiments.
These results suggest that NR2B receptors along with a
proportion of NR2D-containing receptors are likely to
be the most common receptor subtypes in 7-day-old
rat striatum and that NR2A subunits are unlikely to be
involved in the D1 inhibition of striatal NMDA receptors
observed in this study.
D1 receptor activation does not change NMDA
receptor single channel activity in isolated
membrane patches
D1 receptor inhibition of NMDA receptors could not
be observed in outside-out membrane patches from the
cell body; application of SKF-82958 did not change the
single channel conductance, mean open time, mean shut
time or open probability in 21 outside-out patch-clamp
recordings.Theseresultsareimportantbecausetheyshow
that SKF-82958 (20nM) has no direct effect on NMDA
receptor function although much higher concentrations
have been shown to directly inhibit NMDA receptors
(Castro et al. 1999; Cui et al. 2006). Whole-cell currents
are determined by the channel conductance, the open
probability and the channel number. Therefore we hypo-
thesized that D1 inhibition of NMDA responses in
whole-cell recordings may be mediated by a change
in surface receptor number caused by NMDA receptor
trafﬁcking between surface and intracellular receptor
pools, although there is also the possibility that D1
receptors are not colocalized with NMDA receptors in the
somatic membrane patches used for these single channel
recordings. Likewise, Lee et al. (2002) also found that
D1 receptor activation decreased the number of NMDA
receptors expressed on the cell surface.
Non-receptor tyrosine kinase is required
for D1 inhibition of NMDA receptors
The Src family of protein tyrosine kinases, which consists
of Src, Fyn, Lyn, Lck and Yes (Ali & Salter, 2001), has been
shown to up-regulate the activity of NMDA receptors by
phosphorylation(Kohr&Seeburg,1996;Zhengetal.1998;
Ali&Salter,2001).InrecombinantNMDAreceptors,Kohr
& Seeburg (1996) showed that Src potentiated whole cell
currents mediated by NR1/NR2A but not by NR1/NR2B.
Zheng et al. (1998) demonstrated that Src potentiation
was mediated by a decrease in tonic zinc inhibition. Salter
(1998) suggested there might be an additional possibility
thatphosphorylationofNR2Bsubunitsbytyrosinekinase
does not affect channel gating but rather affects another
function such as receptor trafﬁcking, and subsequent
biochemical experiments have uncovered a wide range of
trafﬁcking effects that are modulated by tyrosine kinases
and by interaction with intracellular scaffolding proteins
(reviewed by Wenthold et al. 2003; Lau & Zukin, 2007).
G protein-coupled receptors have been reported to
potentiate NMDA receptor function (Lu et al. 1999)
and trafﬁcking (Dunah & Standaert, 2001; Hallett
et al. 2006) by the activation of Src family kinases.
Heuss et al. (1999) have proposed that a Src-family
tyrosine kinase mediates the metabotropic glutamate
receptor (mGluR) EPSC by associating with the receptor
either directly or via an adaptor protein; furthermore
Benquet et al. (2002) demonstrated that the activation
of mGluR1 potentiates the NMDA current via a G
protein-independent mechanism involving Src kinase
activation. In terms of D1 receptor modulation, Dunah
et al. (2004) showed that deletion of the gene for
the protein tyrosine kinase Fyn, inhibits dopamine D1
receptor-induced enhancement of the abundance of
NR1, NR2A and NR2B subunits in the synaptosomal
membrane fraction and demonstrated that Fyn and
tyrosine phosphorylation are required for D1-dependent
redistribution of NMDA receptor protein (Dunah et al.
2004; Hallett et al. 2006).
In this study intracellular application of lavendustin
A, an inhibitor of non-receptor protein tyrosine kinases,
blocked D1 inhibition of NMDA receptor currents, while
lavendustin B, an inactive analogue of lavendustin A, had
no effect. In addition, intracellular application of PP2, a
selective Src family tyrosine kinase inhibitor, also blocked
D1 inhibition of NMDA currents. These results indicate
D1 inhibition of NMDA currents requires tyrosine kinase
activation.
Dynamin-dependent D1 inhibition
In this study, D1 inhibition of NMDA responses
was blocked by intracellular application of a dynamin
inhibitory peptide. The dynamin inhibitory peptide
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also produced an approximate doubling of the average
whole-cell response to 10μM NMDA. These results
support the concept that normally there is constitutive
turnoverofNMDAreceptorsinthecellmembrane(Roche
et al. 2001; Wenthold et al. 2003; Lavezzari et al. 2004;
Washbourne et al. 2004) and our results suggest this
turnoverisrapid(evenatroomtemperature)witharound
50% of the active pool of receptors spending on average
1min or less on the cell surface. Such rapid receptor
trafﬁcking is not unexpected given that in neonatal
hippocampus, subunit switching of NR2A for NR2B
receptors occurs at CA1 synapses within seconds of a
potentiating stimulus (Bellone & Nicoll, 2007). In tissue
cultured cortical neurones, Washbourne et al. (2004)
estimateanaveragetimeof5minforthefullendo/exocytic
cycleandusingimmuno-goldlabellingthat∼15%oftotal
NMDA receptors are on the cell surface at any given time
while our experiments suggest that in neonatal striatal
neurones ∼50% of receptors are on the cell surface. In
our experiments inhibition of receptor internalization
resulted in an accumulation of receptors on the cell
surface and occlusion of D1 inhibition suggesting that
dynamin-dependent internalization is essential in order
to be able to observe D1-dependent inhibition.
Mechanism of D1 inhibition
NMDA receptor NR2B subunits have one PDZ-binding
motif and one tyrosine phosphorylation motif (YEKL
1472–1475) at the C-terminal, which inﬂuence receptor
internalization (Wenthold et al. 2003). The main site of
tyrosine phosphorylation of NR2B is Y1472 (Nakazawa
et al. 2001). Roche et al. (2001) demonstrated that
the YEKL motif regulates a robust endocytosis of
NMDA receptors in cultured neurons and there was a
developmental decline in NMDA receptor endocytosis
as neurons mature. This is consistent with a decrease
of NR2B subunits together with an increase of NR2A
subunits while neurons are maturing (Watanabe et al.
1993; Monyer et al. 1994; Wenzel et al. 1997; Laurie
et al. 1997). PSD-95 is abundant in the postsynaptic
density (PSD) and is a membrane associated guanylate
kinase (MAGUKs), contributing to anchoring NMDA
receptors at the synapse (Wenthold et al. 2003; Chung
et al. 2004; Lin et al. 2004). PSD-95 associates with the
lastfouraminoacids(ESDV)oftheNR2subunit(Kornau
et al. 1995; Niethammer et al. 1996; Cousins et al. 2008)
and this binding site is very close to Y1472 (Nakazawa
et al. 2001), the main site of tyrosine phosphorylation.
Roche et al. (2001) suggest that phosphorylation
of the NMDA receptor could inhibit the receptor’s
interaction with PSD-95. They concluded that the
disruption of the NMDA receptor–PSD-95 complex
destabilized the NMDA receptor, thereby allowing
receptor internalization. In addition the tyrosine motif
binds to AP-2 adaptor complexes allowing a rapid
internalization of surface NMDA receptors (Bonifacino
& Dell’Angelica, 1999; Lavezzari et al. 2003). Such a
mechanismisconsistentwiththeresultswehaveobserved
here in neonatal rat striatum and with the results of
Gu et al. 2007) showing that in HEK cells coexpressing
D1, NR1, NR2B and PSD-95, in the presence of the
PKA blocker, H89, dopamine caused an inhibition of
the NMDA receptor response that is dependent on
the expression of PSD-95. These observations are also
consistent with the elegant work of Misale and coworkers
(Fiorentinietal.2003,2006)whousedBRETtoshowthat
D1 and NMDA receptors directly interact in transfected
HEK cells and that in cells coexpressing D1, NR1, NR2B
and PSD-95, coactivation of D1 and NMDA receptors
is necessary to observe D1-evoked NMDA receptor
internalization.
Relevance of neonatal D1 inhibition for synaptic
NMDA receptors
The main excitatory input to striatal medium spiny
neurones comes from cortical pyramidal neurones.
At these glutamatergic corticostriatal synapses, NMDA
receptor-dependent synaptic plasticity is modulated by
dopamine D1 and D2 receptors (Calabresi et al. 1992;
Kerr & Wickens, 2001; Surmeier et al. 2007; Shen et al.
2008). Striatal medium spiny neurones fall into two
similar groups, expressing mainly D1 or D2 receptors
corresponding to direct and indirect pathway neurones,
respectively (reviewed by Surmeier et al. 2007). It follows
thatD1modulationofNMDAreceptorswillbeevidentin
directpathwaymediumspinyneuronesandnotinindirect
pathway cells. In neonatal rats this may cause a reduction
in the synaptic strength at corticostriatal synapses in the
directpathway.However,thewhole-cellresponsesstudied
in this paper will include current from both synaptic and
extra-synaptic NMDA receptors and so it is not possible
to predict from our data what the effect of D1 activation
will be on synaptic NMDA receptors in P7 rats, although
themechanismofD1modulationobservedinthisstudyis
consistent with modulation of synaptic receptors in other
systems (Newpher & Ehlers, 2008).
T h ei d e at h a tD 1a c t i v a t i o ne v o k e sat y r o s i n e
kinase-dependent NMDA receptor internalization
appears at ﬁrst sight to be inconsistent with biochemical
experiments studying the effect of D1 receptor activation
on NMDA receptor trafﬁcking in the striatum (Dunah &
Standaert, 2001; Dunah et al. 2004; Hallett et al. 2006).
These show a tyrosine kinase-dependent increase in the
density of synaptic NMDA receptors and stimulation
of receptor trafﬁcking to the dendrites (Hallett et al.
2006) following D1 receptor activation. In addition, in
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adult rats, Chen et al. (2004) and Seamans et al. (2001)
have shown a potentiation of NMDA receptor-mediated
synaptic currents in prefrontal cortex. One possible
explanation for these apparently conﬂicting results may
lie in the difference in NR2A subunit expression which
is almost absent in P7 rat striatum (Monyer et al. 1994;
Portera-Cailliau et al. 1996) but widely expressed in older
rats or in long-term tissue culture. In younger animals
NR2B subunits predominate and these can be rapidly
internalized in response to tyrosine phosphorylation of
the NR2B C-terminal domain (Lavezzari et al. 2003,
2004; Wenthold et al. 2003). In contrast, NR2A subunits
are stabilized by PSD-95 binding at the synapse and
NR2A endocytosis is regulated by a dileucine motif.
These differences mean that the regulation of NMDA
receptortrafﬁckingandsurfacedensityisdevelopmentally
dependent on the presence of NR2A subunits (Newpher
& Ehlers, 2008). Intriguingly, Hallett et al. (2006) show
that in concert with a D1 receptor-dependent increase
in NR2A subunit protein in the dendrites of striatal
neurons in long-term tissue culture, there is an increase
in surface NR2B. It could be that this reﬂects the
movement of triheteromeric NR1/NR2A/NR2B receptors
(Sheng et al. 1994; Chazot & Stephenson, 1997; Tovar
& Westbrook, 1999) into the synapse. Whatever the
underlying mechanisms, the results presented in this
paper suggest that there is a developmental switch in D1
receptor modulation between early in development when
NR2B receptors predominate and D1 receptor activation
down-regulates NMDA receptors, to later in development
when a mixed NR2A/NR2B receptor population is
likely to be present and D1 receptor activation stabilizes
NR2A-containing receptors at the synapse.
In summary, it is clear that the D1 receptor-dependent
inhibition of NMDA receptors in our experiments
in neonatal rats is not mediated by the classical G
protein-dependent pathway but instead involves tyrosine
kinase activation and dynamin-dependent receptor
internalization. We suggest that in these experiments
tyrosine kinase phosphorylation of the C-terminal of
NR2B subunits may interfere with PSD-95 anchoring of
NMDA receptors. As a result, fewer NMDA receptors
remain on the cell surface producing smaller whole cell
currents after D1 receptor activation.
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